Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 6263121, 9 pages
https://doi.org/10.1155/2017/6263121
Research Article

Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease

1Department of Pediatrics, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju 61469, Republic of Korea
2Department of Pharmacology, Chonnam National University Medical School, Gwangju 61469, Republic of Korea
3Division of Clinical Pharmacology, Chonnam National University Hospital, Gwangju 61469, Republic of Korea

Correspondence should be addressed to Gaeun Kang; moc.liamg@gnak.nueag and Young Kuk Cho; ten.liamnah@xcgnuoy

Received 14 July 2017; Accepted 25 September 2017; Published 22 November 2017

Academic Editor: Juan Bueno

Copyright © 2017 Sang Hoon Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Yanagisawa, M. Ayusawa, M. Kato et al., “Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease,” Pediatrics International, vol. 58, no. 11, pp. 1105–1111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Takahashi, T. Oharaseki, Y. Yokouchi, H. Yamada, K. Shibuya, and S. Naoe, “A half-century of autopsy results–incidence of pediatric vasculitis syndromes, especially Kawasaki disease,” Circulation Journal, vol. 76, no. 4, pp. 964–970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. K. H. Lin, S. S. Chang, C. W. Yu et al., “Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis,” British Medical Journal Open, vol. 5, no. 4, article e006703, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Toyono, D. Takagi, J. Oyamada, S. Shimada, M. Aoki-Okazaki, and T. Takahashi, “Coronary artery aneurysm after Kawasaki disease in a single coronary artery,” Circulation Journal, vol. 77, no. 9, pp. 2409–2411, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. B. W. McCrindle, A. H. Rowley, J. W. Newburger et al., “Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association,” Circulation, vol. 135, no. 17, pp. e927–e999, 2017. View at Publisher · View at Google Scholar
  6. D. W. Lee, Y. H. Kim, M. C. Hyun, T. C. Kwon, and S. B. Lee, “NT-proBNP as a useful tool in diagnosing incomplete Kawasaki disease,” Korean Journal of Pediatrics, vol. 53, no. 4, pp. 519–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. J. Lee, H. J. Kim, H. S. Kim, and S. J. Sohn, “NT-pro BNP: a new diagnostic screening tool for Kawasaki disease,” Korean Journal of Pediatrics, vol. 49, no. 5, pp. 539–544, 2006. View at Publisher · View at Google Scholar
  8. A. Nir, A. Lindinger, M. Rauh et al., “NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies,” Pediatric Cardiology, vol. 30, no. 1, pp. 3–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Rawat and S. Singh, “Biomarkers for diagnosis of Kawasaki disease,” Indian Pediatrics, vol. 52, no. 6, pp. 473-474, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Eleftheriou, M. Levin, D. Shingadia, R. Tulloh, N. J. Klein, and P. A. Brogan, “Management of Kawasaki disease,” Archives of Disease in Childhood, vol. 99, no. 1, pp. 74–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. K. Seaton and A. Kharbanda, “Evidence-based management of Kawasaki disease in the emergency department,” Pediatric Emergency Medicine Practice, vol. 12, no. 1, pp. 1–20, 2015. View at Google Scholar
  12. M. Weber and C. Hamm, “Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine,” Heart, vol. 92, no. 6, pp. 843–849, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Nevo, M. Erlichman, N. Algur, and A. Nir, “N-terminal pro B-type natriuretic peptide levels in infants and children with acute non-cardiac diseases,” Israel Medical Association Journal, vol. 13, no. 7, pp. 420–424, 2011. View at Google Scholar
  14. S. Y. Cho, Y. Kim, S. H. Cha, J. T. Suh, M. Y. Han, and H. J. Lee, “Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?” Annals of Clinical and Laboratory Science, vol. 41, no. 4, pp. 360–363, 2011. View at Google Scholar